|
1
|
Yu LM and Xu Y: Epigenetic regulation in
cardiac fibrosis. World J Cardiol. 7:784–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dai H, Jia G, Liu X, Liu Z and Wang H:
Astragalus polysaccharide inhibits isoprenaline-induced cardiac
hypertrophy via suppressing Ca2+-mediated calcineurin/NFATc3 and
CaMKII signaling cascades. Environ Toxicol Pharmacol. 38:263–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu H, Tian A, Wu J, Yang C, Xing R, Jia P,
Yang L, Zhang Y, Zheng X and Li Z: Danshensu inhibits β-adrenergic
receptors-mediated cardiac fibrosis by ROS/p38 MAPK axis. Biol
Pharm Bull. 37:961–967. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morita N, Mandel WJ, Kobayashi Y and
Karagueuzian HS: Cardiac fibrosis as a determinant of ventricular
tachyarrhythmias. J Arrhythm. 30:389–394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim J, Eckhart AD, Eguchi S and Koch WJ:
Beta-adrenergic receptor-mediated DNA synthesis in cardiac
fibroblasts is dependent on transactivation of the epidermal growth
factor receptor and subsequent activation of extracellular
signal-regulated kinases. J Biol Chem. 277:32116–32123. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Wang HX, Zhang YJ, Yang YH, Lu ML,
Zhang J, Li ST, Zhang SP and Li G: Astragaloside IV attenuates
inflammatory cytokines by inhibiting TLR4/NF-кB signaling pathway
in isoproterenol-induced myocardial hypertrophy. J Ethnopharmacol.
150:1062–1070. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang X, Cao X, Huang Y, Chen J, Yao X,
Zhao M, Liu Y, Meng J, Li P, Li Z, et al: Effects of treatment with
Astragalus Membranaceus on function of rat leydig cells. BMC
Complement Altern Med. 15:2612015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mei M, Tang F, Lu M, He X, Wang H, Hou X,
Hu J, Xu C and Han R: Astragaloside IV attenuates apoptosis of
hypertrophic cardiomyocyte through inhibiting oxidative stress and
calpain-1 activation. Environ Toxicol Pharmacol. 40:764–773. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao P, Wang Y, Zeng S, Lu J, Jiang TM and
Li YM: Protective effect of astragaloside IV on
lipopolysaccharide-induced cardiac dysfunction via downregulation
of inflammatory signaling in mice. Immunopharmacol Immunotoxicol.
37:428–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen P, Xie Y, Shen E, Li GG, Yu Y, Zhang
CB, Yang Y, Zou Y, Ge J, Chen R and Chen H: Astragaloside IV
attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in
coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol.
658:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu N, Xing R, Yang C, Tian A, Lv Z, Sun
N, Gao X, Zhang Y and Li Z: HIP-55/DBNL-dependent regulation of
adrenergic receptor mediates the ERK1/2 proliferative pathway. Mol
Biosyst. 10:1932–1939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu Y, Li S, Wu H, Bian Z, Xu J, Gu C, Chen
X and Yang D: Beneficial effects of astragaloside IV against
angiotensin II-induced mitochondrial dysfunction in rat vascular
smooth muscle cells. Int J Mol Med. 36:1223–1232. 2015.PubMed/NCBI
|
|
13
|
Wang SG, Xu Y, Xie H, Wang W and Chen XH:
Astragaloside IV prevents lipopolysaccharide-induced injury in H9C2
cardiomyocytes. Chin J Nat Med. 13:127–132. 2015.PubMed/NCBI
|
|
14
|
Somanna NK, Valente AJ, Krenz M, Fay WP,
Delafontaine P and Chandrasekar B: The Nox1/4 dual inhibitor
GKT137831 or Nox4 knockdown Inhibits Angiotensin-II-Induced adult
mouse cardiac fibroblast proliferation and migration. AT1
physically associates with Nox4. J Cell Physiol. 231:1130–1141.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Porter KE and Turner NA: Cardiac
fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther.
123:255–278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye Y, Lv X, Wang MH, Zhu J, Chen SQ, Jiang
CY and Fu GS: Alendronate prevents angiotensin II-induced collagen
I production through geranylgeranylation-dependent RhoA/Rho kinase
activation in cardiac fibroblasts. J Pharmacol Sci. 129:205–209.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Segura AM, Frazier OH and Buja LM:
Fibrosis and heart failure. Heart Fail Rev. 19:173–185. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tao H, Yang JJ, Shi KH, Deng ZY and Li J:
DNA methylation in cardiac fibrosis: New advances and perspectives.
Toxicology. 323:125–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Che X, Wang Q, Xie Y, Xu W, Shao X, Mou S
and Ni Z: Astragaloside IV suppresses transforming growth factor-β1
induced fibrosis of cultured mouse renal fibroblasts via inhibition
of the MAPK and NF-B signaling pathways. Biochem Biophys Res
Commun. 464:1260–1266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qi Q, Mao Y, Yi J, Li D, Zhu K and Cha X:
Anti-fibrotic effects of Astragaloside IV in systemic sclerosis.
Cell Physiol Biochem. 34:2105–2116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Wang X, Han C, Wang X, Xing G, Zhou
L, Li G and Niu Y: Astragaloside IV suppresses collagen production
of activated hepatic stellate cells via oxidative stress-mediated
p38 MAPK pathway. Free Radic Biol Med. 60:168–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Wang F, Zhang Y, Kang Y, Wang H,
Si M, Su L, Xin X, Xue F, Hao F, et al: Celecoxib prevents pressure
overload-induced cardiac hypertrophy and dysfunction by inhibiting
inflammation, apoptosis and oxidative stress. J Cell Mol Med.
20:116–127. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu B, Zhang J, Liu W, Liu N, Fu X, Kwan H
and Liu S, Liu B, Zhang S, Yu Z and Liu S: Calycosin inhibits
oxidative stress-induced cardiomyocyte apoptosis via activating
estrogen receptor-α/β. Bioorg Med Chem Lett. 26:181–185. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kayama Y, Raaz U, Jagger A, Adam M,
Schellinger IN, Sakamoto M, Suzuki H, Toyama K, Spin JM and Tsao
PS: Diabetic cardiovascular disease induced by oxidative stress.
Int J Mol Sci. 16:25234–25263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fournier P, Fourcade J, Roncalli J,
Salvayre R, Galinier M and Causse E: Homocysteine in chronic heart
failure. Clin Lab. 61:1137–1145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murdoch CE, Zhang M, Cave AC and Shah AM:
NADPH oxidase-dependent redox signalling in cardiac hypertrophy,
remodelling and failure. Cardiovasc Res. 71:208–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao HH, Zhang N, Feng H, Zhang N, Ma ZG,
Yang Z, Yuan Y, Bian ZY and Tang QZ: Oleanolic acid alleviated
pressure overload-induced cardiac remodeling. Mol Cell Biochem.
409:145–154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao Z, Hu W, Yin S, Huang Z, Zhu Q, Chen
J, Zang Y, Dong L and Zhang J: 3,3′-Diindolymethane ameliorates
adriamycin-induced cardiac fibrosis via activation of a
BRCA1-dependent anti-oxidant pathway. Pharmacol Res. 70:139–146.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liou JY, Chen YL, Loh SH, Chen PY, Hong
CY, Chen JJ, Cheng TH and Liu JC: Magnolol depresses
urotensin-II-induced cell proliferation in rat cardiac fibroblasts.
Clin Exp Pharmacol Physiol. 36:711–716. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chan P, Liu JC, Lin LJ, Chen PY, Cheng TH,
Lin JG and Hong HJ: Tanshinone IIA inhibits angiotensin II-induced
cell proliferation in rat cardiac fibroblasts. Am J Chin Med.
39:381–394. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang W, Chen XF, Huang YJ, Chen QQ, Bao
YJ and Zhu W: 2,3,4′, 5-Tetrahydroxystilbene-2-O-β-D-glucoside
inhibits angiotensin II-induced cardiac fibroblast proliferation
via suppression of the reactive oxygen species-extracellular
signal-regulated kinase 1/2 pathway. Clin Exp Pharmacol Physiol.
39:429–437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu M, Zheng Y, Sun HX and Yu DJ:
Inhibitory effects of enalaprilat on rat cardiac fibroblast
proliferation via ROS/P38MAPK/TGF-β1 signaling pathway. Molecules.
17:2738–2751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shyu KG, Wang BW, Chen WJ, Kuan P and Lin
CM: Angiotensin II mediates urotensin II expression by hypoxia in
cultured cardiac fibroblast. Eur J Clin Invest. 42:17–26. 2012.
View Article : Google Scholar : PubMed/NCBI
|
